Neural organoids are three-dimensional, self-organizing cellular models generated from human pluripotent stem cells or primary tissues. Because these advanced 3D models can recapitulate many features of the human brain in vitro, neuroscientists are increasingly relying on neural organoids to investigate neurodevelopmental pathways, establish phenotypic models of disease, examine the impact of neurotoxicants, and explore unprecedented therapeutic strategies including precision and neuroregenerative medicine.
Featured on this page:
Discover how Axion’s next-generation live-cell analysis tools can accelerate your disease research and drug discovery workflows:
>> Maestro multielectrode array (MEA) platform — Assess key parameters of neural network function in real time with Axion’s nonstop, noninvasive, label-free Maestro MEA and powerful, intuitive software.
>> Omni imaging platform — Visualize the growth, differentiation, cell morphology, and cell viability of neural organoids as they develop with Axion’s automated, AI-supported live-cell imaging tools.
Coffee Break Webinars
Sit back with a cup of coffee and enjoy these 10 minute webinars.
Measuring oscillatory waves in cerebral organoids
Neuronal Organoid activity mimics the fetal brain
The spectrum in a dish: Using neurophysiology to build a human iPSC model of autism
PBS Documentary: The Cannabis Question
Start watching at 22:50 to see how Dr. Alysson Muotri is using neural organoids to explore the impact of CBD on autism spectrum disorder.
The Cannabis Question
Browse 35 selected publications illustrating how scientists around the world are using neural organoids for disease research and therapeutic discovery.
Autism spectrum disorders
Congenital central hypoventilation syndrome (CCHS)
Focal cortical dysplasia
Myasthenia gravis (NMJ)
Neurodevelopment and neurodegeneration
Organoid development and optimization
Application Notes and Culture Protocols
Learn how easy it is to monitor neural organoids on Axion's hands-free, automated platforms.
In the News
Learn about opportunities and challenges in neural organoid technology.